Stay updated on Ligelizumab in CSU Adolescents & Adults Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab in CSU Adolescents & Adults Clinical Trial page.

Latest updates to the Ligelizumab in CSU Adolescents & Adults Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe Taiwan site location in the study locations was updated from Taoyuan District to Taoyuan, Taiwan, 33305, indicating a shift to the city-level designation while preserving the same postal code.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page footer revision/version label has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision v3.5.0 was removed and revision v3.5.2 was added.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 as part of a minor update.SummaryDifference0.0%

- Check91 days agoChange Detected- The revision label on the page updated from v3.4.1 to v3.4.2; no substantive content changes to the study details are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Ligelizumab in CSU Adolescents & Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab in CSU Adolescents & Adults Clinical Trial page.